RUDO SHOKO: Open Payments
NPI 1366871543 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 26 payments from 5 companies in 2025. Trend: 2023 $925 · 2024 $535 · 2025 $1,068
Food & beverage: $1,059Education: $9
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $400 |
| Otsuka America Pharmaceutical, Inc. | 8 | $296 |
| ACADIA Pharmaceuticals Inc | 4 | $143 |
| Alkermes, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 2 | $104 |
Products named: REXULTI, INGREZZA, NUPLAZID, ARISTADA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
